The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

WEIGHT-LOSS drugs that last week became available on the NHS will not be available through Jersey’s publicly funded healthcare system for treating obesity until September at the earliest. A government ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

Food noise is the internal chatter you have about eating that can lead to unhealthy eating habits. Learn more about what it ...

Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...

It was specifically designed to minimize engagement with central nervous system pathways implicated in the psychiatric side effects observed in some smoking cessation therapies and first-generation ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in China. At first, Chinese pharmaceutical companies rushed ...

Sunday on PBS News Weekend, three years after the end of Roe v. Wade, a decades-old movement is exploring new ways to circumvent abortion bans and restrictions. A former FDA head discusses the science ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained ...